Welsh contract services firm Penn Pharmaceuticals has reorganised its transport and delivery infrastructure in the first phase of a £12m (€13.3m) expansion at its facility in Tredegar.
Novartis is investing $250m (€170m) to construct a facility in China focused on research, development and manufacture of APIs and has earmarked a further $1bn to expand its R&D activities in the country.
O’Hara Technologies has launched a lab-scale tablet coating system that incorporates a blender and tray dry oven inserts to cut capital expense and GMP spaced needed perform these tasks.
Nokia, SAP and G&D are forming a company to provide anti-counterfeiting services which will draw on the firms’ respective expertise in mobile phones, supply chain technology and encryption.
Portuguese CMO Hovione has bought an aseptic spray-drying line from US firm Acusphere and says that the demand for the technology is increasing as drug firms aim to boost bioavailability.
Novavax has entered into a deal with Xcellerex to boost production of its H1N1 vaccine, which is entering clinical trials in Mexico, using the CMO’s FlexFactory disposable biomanufacturing platform.
GEA Niro has begun offering contract spray-drying services for drug candidates and clinical trial supplies from its “Test Center” in Copenhagen, Denmark and wants the drug industry to know about the technique’s advantages.
BASF says its new Soluplus excipient will help meet demand for solubilising agents that are compatible with hot melt extrusion (HME) manufacturing methods.
Arch Pharmalabs is continuing its push to serve innovative pharma by adding simulated moving bed (SMB) technology, becoming the first in India to offer the offer the system for plant scale API manufacture.
Packaging group Stralfors says its recent collaboration with Novo Nordisk proves that its service plan is ideal for projects with strict time-to-market requirements.
Reaxa will set up an Indian subsidiary to manage supply chain, commercial scale production and application development for its growing number of customers in the country.
We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
Symphony Metro Pharma Solutions and HP Solutions have created a new application that, they claim, can help drug marketeers identify activities with the greatest revenue potential.
UK pharmaceutical test media supplier Cherwell Laboratories says its receipt of BSI ISO 9001:2008 accreditation demonstrates its commitment to quality.
Rexam has merged its Pharma, Primary Packaging and Prescription units into a new Healthcare division to keep pace with the increasingly globalized drug manufacturing industry's regulatory demands.
Northern Irish Packaging specialist Sepha says increasing pressure to reduce waste is driving drug industry demand for its range of Press-Out deblistering technologies.
Japanese CRO CMIC says rising demand for Medidata Solutions’ Rave EDC system in Asia drove its decision to seek top-level provider status under the US firm’s accreditation scheme.
ethica Clinical has added biomarker data analysis technology to its roster of services in a C$1.25m (€782,899) deal with fellow Canadian CRO Matrix Pharma.
Ampac Fine Chemicals (AFC) has added three new commercial-scale Hastelloy liquid-liquid centrifuges to its API making business in a move that, it says, will increase batch size and lower manufacturing costs.
Revenues from Pall’s biopharmaceuticals division grew in fiscal 2009, excluding foreign currency changes, with the company benefiting from the “thriving market” for vaccines and expanding adoption of single-use systems.
US contract research organisation (CRO) Advion BioServices has expanded its biomarker business in an effort to meet growing industry demand for pharmacological analysis.
Struggling biotech Targeted Genetics (TG) has sold certain patents and AAV manufacturing technology to fellow US group Genzyme in a $7m deal that “shifts the firm out of crisis mode,” according to CEO Susan Robinson.
Biotechnology firm Cel-Sci claims the “True Cold” low-temperature fill and finish service at its new manufacturing facility near Baltimore, Maryland is a first for the global contracting sector.
Researchers believe they are a step closer to creating superefficient industrial catalysts after a team made platinum-on-gold bimetallic nanorods that are soluble in organic solvents.
Cobra Biomanufacturing’s new Adenovirus manufacturing and process services contract is further evidence of the health of EU biologicals market, according to business development manager Philip Ridley-Smith.
Basel-headquartered Roche has paid fellow Swiss firm Lonza $290m (€203m) for its Singapore biologics plant in a bid to secure long-term manufacturing capacity for biotech cancer drugs.
Mantecorp is using the Control and Communication Link (CC-Link) open fieldbus network to improve the environmental credentials of its facility in Rio de Janeiro, Brazil.
GEA Lyophil, part of GEA Pharma Systems, has won a contract to supply Chinjese drugmaker Zheijang Hisun Pharmaceutical with freeze drying systems and automatic loading units.
US drug giant Pfizer has joined the growing list of organisations seeking to boost trial recruitment via the web, teaming up with IT firm Private Access to create a website designed to “increase clinical trial awareness and participation.”
Amcor has temporarily halted trading on the Australian stock exchange, fuelling rumours that the group is finally about to move for Rio Tinto’s Alcan pharmaceutical packaging unit.
Biotech processes will be improved by using Sani-Tech Ultra tubing, according to its manufacturer that claims the product has a longer lifespan and lower concentration of extractables than its competitors.
Demand for downstream processing products from biotechs drove the continued recovery of Millipore’s bioprocessing division in Q2 but operating income remained flat.
AmerisourceBergen’s contract packaging business believes the outlook for the sector is improving after it posted an 11 per cent rise in operating income in Q3.
Beauty packaging specialist Rexam is considering issuing new equity to service its burdensome debt pile, after market conditions failed to improve in the last quarter.
Austria’s Borealis has brought its Bormed LE6609-PH BFS grade plastic back to market in a move that, it claims, will allow converters to speed up their production cycles by reducing autoclave residence time.
Australian group Amcor has confirmed that talks about a takeover of Alcan’s pharmaceutical packaging business are still ongoing but says that no binding agreement has yet been reached.
SAFC’s bioscience unit and Sartorius Stedim Biotech (SSB) have teamed up to create a suite of fluid management solutions that they hope will prove irresistible to the booming biomanufacturing sector.
Ultrasonic particle engineering specialist Prosonix has been accredited under the ISO 9001:2008 quality scheme, after an inspection by the UK unit of independent auditing group SGS.
Novasep has bolstered its upstream processing capabilities by acquiring Henogen, a Belgium-based CMO that has biotech development and cGMP manufacturing expertise.
US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production.
Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...
Bispecific antibodies (BisAbs), which can bind to two distinct antigens, are prone to high levels of aggregate (10-30%), challenging traditional platform...
Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...
